Taken together, we demonstrated the induction of autoreactive CD49d+CD154+ lymphocytes in MS patients in PBMCs exposed to myelin peptides and confirmed the role of CD154-CD40 interaction in this process. Here, CD40 is linked to myeloid sarcoma.